Cullinan Therapeutics, Inc. (CGEM)
15.51
+0.98
(+6.74%)
USD |
NASDAQ |
Oct 02, 16:00
15.50
-0.01
(-0.06%)
After-Hours: 06:58
Cullinan Therapeutics Market Cap : 1.001B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.001B |
| October 01, 2026 | 937.91M |
| September 30, 2026 | 990.84M |
| September 29, 2026 | 983.10M |
| September 28, 2026 | 965.02M |
| September 25, 2026 | 955.99M |
| September 24, 2026 | 996.65M |
| September 23, 2026 | 1.089B |
| September 22, 2026 | 1.399B |
| September 21, 2026 | 1.378B |
| September 18, 2026 | 1.361B |
| September 17, 2026 | 1.379B |
| September 16, 2026 | 1.332B |
| September 15, 2026 | 1.326B |
| September 14, 2026 | 1.317B |
| September 11, 2026 | 1.329B |
| September 10, 2026 | 1.356B |
| September 09, 2026 | 1.376B |
| September 08, 2026 | 1.400B |
| September 04, 2026 | 1.426B |
| September 03, 2026 | 1.430B |
| September 02, 2026 | 1.441B |
| September 01, 2026 | 1.407B |
| August 31, 2026 | 1.425B |
| August 28, 2026 | 1.401B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.459B |
| August 26, 2026 | 1.475B |
| August 25, 2026 | 1.481B |
| August 24, 2026 | 1.408B |
| August 21, 2026 | 1.399B |
| August 20, 2026 | 1.380B |
| August 19, 2026 | 1.454B |
| August 18, 2026 | 1.345B |
| August 17, 2026 | 1.329B |
| August 14, 2026 | 1.313B |
| August 13, 2026 | 1.268B |
| August 12, 2026 | 1.265B |
| August 11, 2026 | 1.267B |
| August 10, 2026 | 1.180B |
| August 07, 2026 | 1.144B |
| August 06, 2026 | 1.159B |
| August 05, 2026 | 1.137B |
| August 04, 2026 | 1.133B |
| August 03, 2026 | 1.006B |
| July 31, 2026 | 1.022B |
| July 30, 2026 | 1.085B |
| July 29, 2026 | 1.066B |
| July 28, 2026 | 1.082B |
| July 27, 2026 | 1.079B |
| July 24, 2026 | 1.059B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Climb Bio, Inc. | 628.35M |
| MapLight Therapeutics, Inc. | 446.19M |
| Arrowhead Pharmaceuticals, Inc. | 9.059B |
| Oncolytics Biotech, Inc. | 78.65M |
| Sangamo Therapeutics, Inc. | 61.11M |
Market Cap Related Metrics
| Price to Book Value | 3.112 |
| Price | 15.51 |
| Earnings Yield | -21.88% |